Zolinza

vorinostat · Merck & Co.

Drug timelines are a Plus or Pro feature.

63 regulatory and trial events tracked for Zolinza, covering 2006-10-06 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Vorinostat in Treating Patients With Metastatic Melanoma of the Eye [Phase 2]